23 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
during the course of employment, and which relate to or are reasonably capable or being used in our current or planned business or R&D are our exclusive … resources than we have. This enables them, among other things, to leverage their financial resources to make greater R&D, marketing and promotion investments
8-K/A
EX-99.8
0sbxo2p8xuu
11 Aug 23
Financial Statements and Exhibits
9:12pm
8-K/A
EX-99.9
m1xvlug 7kkmu
11 Aug 23
Financial Statements and Exhibits
9:12pm
8-K/A
EX-99.7
myleccpg
11 Aug 23
Financial Statements and Exhibits
9:12pm
8-K
EX-99.3
73bd1f36rz
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-99.2
adnkeyek08hbuedje0
27 Jul 23
Index to Financial Statements
5:28pm
8-K
3hsbchyx22r ajity
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-99.1
ylpmc7i6frez7agdvw1
27 Jul 23
Index to Financial Statements
5:28pm
DEFM14A
jhdm5j glj9myn
12 May 23
Proxy related to merger
5:00pm
424B3
gzwknj 3au
12 May 23
Prospectus supplement
4:33pm